Table 2.
Variables | Low anxiety group (LA − G), 209 eyes |
High anxiety group (HA − G), 42 eyes |
P value |
---|---|---|---|
Age, y | 53.05 ± 12.16 | 54.14 ± 16.87 | 0.691* |
Sex, male/female | 89/120 | 18/24 | 0.974† |
Hypertension, n (%) | 37(17.7%) | 10(23.8%) | 0.355† |
Diabetics, n (%) | 8(3.8%) | 2(4.8%) | 0.778† |
CCT, µm | 539.12 ± 48.06 | 527.22 ± 34.98 | 0.184* |
Axial length, mm | 25.29 ± 1.94 | 25.38 ± 1.47 | 0.764* |
PPA/Disc area, per 1 µm larger (%) | 46.01 ± 54.13 | 35.27 ± 35.66 | 0.219† |
Tilt ratio | 1.20 ± 0.22 | 1.20 ± 0.16 | 0.978† |
Torsion ratio | 88.97 ± 9.69 | 87.33 ± 7.59 | 0.304† |
VF MD, dB | − 4.55 ± 5.49 | − 3.54 ± 4.18 | 0.206* |
VF PSD, dB | 4.66 ± 3.70 | 3.78 ± 3.12 | 0.148* |
VF MD progression rate, dB/year | − 0.55 ± 0.58 | − 0.76 ± 0.73 | 0.310* |
RNFL thickness loss rate, µm/year | − 0.68 ± 1.39 | − 1.96 ± 2.23 | 0.021* |
Follow-up duration (month) | 63.85 ± 30.92 | 56.95 ± 38.26 | 0.379* |
Mean IOP | 13.76 ± 3.00 | 14.76 ± 3.02 | 0.049* |
Peak IOP | 17.43 ± 4.12 | 18.86 ± 4.32 | 0.043* |
IOP fluctuation | 5.50 ± 3.41 | 6.50 ± 3.08 | 0.080* |
Mean blood pressure | 94.48 ± 12.503 | 92.45 ± 6.21 | 0.264* |
Disc hemorrhage | 7(3.3%) | 5(11.9%) | 0.018† |
Heart rate variability | 35.09 ± 18.99 | 42.10 ± 29.86 | 0.150* |
CCT, central corneal thickness; PPA, peripapillary atrophy; VF, visual field; MD, mean deviation; PSD, pattern standard deviation; RNFL, retinal nerve fiber layer; IOP, intraocular pressure.
*The comparison was performed using independent samples t-test.
†The comparison was performed using a chi-squared test.
Continuous data are mean ± mean standard deviation unless otherwise indicated.
Statistically significant values appear in boldface.